Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting

Journal of Lipid Research

Volumn 45, Issue 12, 2004, Pages 2221-2226

  Koch, Werner ^a   Mehilli, Julinda ^a   Pfeufer, Arne ^a,b   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

APOE alleles; APOE haplotypes; Coronary artery disease; TaqMan genotyping

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

APOLIPOPROTEINS E; CORONARY RESTENOSIS; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STENTS; THROMBOSIS;

EID: 10044250201     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400148-JLR200     Document Type: Article

References (30)

1. Lincoff, A. M. 2000. Stent scrutiny. J. Am. Med. Assoc. 284: 1839-1841.
2. 1 phase. J. Biol. Chem. 273: 20156-20161.
3. Zhu, B., D. G. Kuhel, D. P. Witte, and D. Y. Hui. 2000. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am. J. Pathol. 157: 1839-1848.
4. De Geest, B., Z. Zhao, D. Collen, and P. Holvoet. 1997. Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice. Circulation. 96: 4349-4356.
5. Siest, G., T. Pillot, A. Régis-Bailly, B. Leininger-Muller, J. Steinmetz, M-M. Galteau, and S. Visvikis. 1995. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin. Chem. 41: 1068-1086.
6. Breslow, J. L. 2000. Genetics of lipoprotein abnormalities associated with coronary heart disease susceptibility. Annu. Rev. Genet. 34: 233-254.
7. Artiga, M. J., M. J. Bullido, I. Sastre, M. Recuero, M. A. Garcia, J. Aldudo, J. Vásquez, and F. Valdivieso. 1998. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E. FEBS Lett. 421: 105-108.
8. Lambert, J-C., T. Brousseau, V. Defosse, A. Evans, D. Arveiler, J-B. Ruidavets, B. Haas, J-P. Cambou, G. Luc, P. Ducimetière, F. Cambien, M-C. Chartier-Harlin, and P. Amouyel. 2000. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum. Mol. Genet. 9: 57-61.
9. Koch, W., A. Ehrenhaft, K. Griesser, A. Pfeufer, J. Müller, A. Schömig, and A. Kastrati. 2002. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin. Chem. Lab. Med. 40: 1123-1131.
10. Hirashiki, A., Y. Yamada, Y. Murase, Y. Suzuki, H. Kataoka, Y. Morimoto, T. Tajika, T. Murohara, and M. Yokota. 2003. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J. Am. Coll. Cardiol. 42: 1429-1437.
11. Wang, X. L., R. M. McCredie, and D. E. L. Wilcken. 1995. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arteriosder. Thromb. Vasc. Biol. 15: 1030-1034.
12. Stengård, J. H., K. M. Weiss, and C. F. Sing. 1998. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum. Genet. 103: 234-241.
13. Gerdes, L. U., C. Gerdes, K. Kervinen, M. Savolainen, I. C. Klausen, P. S. Hansen, Y. A. Kesäniemi, and O. Færgeman. 2000. The apolipoprotein ε4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian Simvastatin Survival Study. Circulation. 101: 1366-1371.
14. Miyata, M., and J. D. Smith. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat. Genet. 14: 55-61.
15. Mui, S., M. Briggs, H. Chung, R. B. Wallace, T. Gomez-Isla, G. W. Rebeck, and B. T. Hyman. 1996. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the ε4 allele. Neurology. 47: 196-201.
16. Paik, Y-K., D. J. Chang, C. A. Reardon, M. D. Walker, E. Taxman, and J. M. Taylor. 1988. Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J. Biol. Chem. 263: 13340-13349.
17. van Bockxmeer, F. M., C. D. S. Mamotte, F. R. Gibbons, and R. R. Taylor. 1994. Apolipoprotein ε4 homozygosity-a determinant of restenosis after coronaly angioplasty. Atherosclerosis. 110: 195-202.
18. van Bockxmeer, F. M., C. D. S. Mamotte, F. A. Gibbons, V. Burke, and R. R. Taylor. 1995. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 92: 2066-2071.
19. Damaraju, S., Q-T. Yu, F. Safavi, and A. J. Marian. 1995. Apolipoprotein protein ε4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 75: 1181-1183.
20. Samani, N.J., D. S. Martin, M. Brack, J. Cullen, R. Wallis, D. Lodwick, A. Chauhan, A. Harley, J. R. Thompson, A. H. Gershlick, and D. P. de Bono. 1996. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty. Atherosclerosis. 125: 209-216.
21. Schömig, A., A. Kastrati, H. Mudra, R. Blasini, H. Schühlen, V. Klauss, G. Richardt, and F-J. Neumann. 1994. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation. 90: 2716-2724.
22. Schömig, A., F-J. Neumann, A. Kastrati, H. Schühlen, R. Blasini, M. Hadamitzky, H. Walter, E-M. Zitzmann-Roth, G. Richardt, E. Alt, C. Schmitt, and K. Ulm. 1996. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N. Engl. J. Med. 334: 1084-1089.
23. Kashyap, V. S., S. Santamarina-Fojo, D. R. Brown, C. L. Parrott, D. Applebaum-Bowden, S. Meyn, G. Talley, B. Paigen, N. Maeda, and H. B. Brewer, Jr. 1995. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J. Clin. Invest. 96: 1612-1620.
24. Linton, M. F., J. B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
25. Farb, A., D. K. Weber, F. D. Kolodgie, A. P. Burke, and R. Virmani. 2002. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 105: 2974-2980.
26. Komatsu, R., M. Ueda, T. Naruko, A. Kojima, and A. E. Becker. 1998. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistoclieniical analyses. Circulation. 98: 224-233.
27. Hui, D. Y., J. A. K. Harmony, T. L. Innerarity, and R. W. Mahley. 1980. Immunoregulatory plasma lipoproteins. J. Biol. Chem. 255: 11775-11781.
28. Hallman, D. M., E. Boerwinkle, N. Saha, C. Sandholzer, H. J. Menzel, A. Csáźr, and G. Utermann. 1991. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49: 338-349.
29. Kimura, T., S. Kaburagi, T. Tamura, H. Yokoi, Y. Nakagawa, H. Yokoi, N. Hamasaki, H. Nosaka, M. Nobuyoshi, G. S. Mintz, J. J. Popma, and M. B. Leon. 1997. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation. 96: 475-483.
30. Grewe, P. H., T. Deneke, A. Machraoui, J. Barmeyer, and K-M. Müller. 2000. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J. Am. Coll. Cardiol. 35: 157-163.